Internal Medicine, Nephrology · Southfield, MI
NPI
1306111463
Since 2012
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
22250 Providence Dr Ste 406
Southfield, MI, 48075
Phone (248) 557-9010
Groups this clinician bills Medicare through
Medicare paid, 2024
$147K
1,752 services
Medicare patients, 2024
449
Average age 73
Drug cost, 2024
$491K
1,815 prescriptions
Company payments, 2025
$5,489
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yassir Sirajeldin was code 99232 (hospital e&m - subsequent), 444 times for 196 patients. In total Yassir Sirajeldin billed 1,752 services in 23 codes, and Medicare paid $147K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 444 | 196 | $62.74 | $28K |
| 99233 Hospital E&M - Subsequent | Facility | 282 | 99 | $94.51 | $27K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 230 | 122 | $13.01 | $2,992 |
| 90935 Hemodialysis | Facility | 139 | 73 | $56.22 | $7,814 |
| 99223 Hospital E&M - Initial | Facility | 112 | 101 | $134.58 | $15K |
| 99214 Office E&M - Established | Office | 103 | 64 | $66.22 | $6,820 |
| 99213 Office E&M - Established | Office | 89 | 68 | $60.44 | $5,379 |
| 90960 ESRD Related Services (not dialysis) | Office | 82 | 20 | $276.52 | $23K |
| 90961 ESRD Related Services (not dialysis) | Office | 48 | 13 | $225.39 | $11K |
| 99215 Office E&M - Established | Office | 46 | 30 | $82.49 | $3,795 |
| 99222 Hospital E&M - Initial | Facility | 37 | 34 | $105.16 | $3,891 |
| 90966 ESRD Related Services (not dialysis) | Office | 19 | 11 | $217.04 | $4,124 |
| 99215 Office E&M - Established | Facility | 19 | 13 | $91.06 | $1,730 |
| 36415 Venipuncture Blood Collection | Office | 19 | 15 | $8.65 | $164 |
| 99204 Office E&M - New | Office | 12 | 12 | $120.82 | $1,450 |
By year: 2022 $196K for 2,312 services; 2023 $158K for 1,860 services; 2024 $147K for 1,752 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 19 | 15 | $8.65 | $164 |
Medicare prescription drug claims, 2024
In 2024, the drug Yassir Sirajeldin prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 214 prescriptions and refills. In total Yassir Sirajeldin wrote 1,815 Medicare prescriptions that cost $491K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 214 | 338 | 38 | $173K |
| Carvedilol Generic | 179 | 449 | 55 | $2,393 |
| Amlodipine-Olmesartan Amlodipine Bes/Olmesartan Med | 177 | 525 | 64 | $11K |
| Torsemide Generic | 106 | 290 | 46 | $1,825 |
| Amlodipine Besylate Generic | 58 | 166 | 24 | $294 |
| Calcium Acetate Generic | 54 | 111 | 17 | $6,193 |
| Amlodipine Besylate-Benazepril Amlodipine Besylate/Benazepril | 53 | 157 | 19 | $1,908 |
| Hydralazine Hcl Generic | 49 | 121 | 22 | $848 |
| Furosemide Generic | 47 | 115 | 16 | $482 |
| Spironolactone Generic | 42 | 118 | 15 | $670 |
| Chlorthalidone Generic | 40 | 86 | 12 | $509 |
| Lokelma Sodium Zirconium Cyclosilicate | 39 | 70 | 15 | $42K |
| Lisinopril Generic | 37 | 92 | 11 | $110 |
| Atorvastatin Calcium Generic | 36 | 92 | 15 | $490 |
| Losartan Potassium Generic | 36 | 106 | 18 | $325 |
Brand drugs: - claims; generic drugs: 1,395 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yassir Sirajeldin $5,489 ($5,489 in general payments such as food, travel and fees) from 19 companies. The largest payer was Aurinia Pharma U.S., Inc. with $3,324.
| Company | Payments | Amount |
|---|---|---|
| Aurinia Pharma U.S., Inc. AUPH | 5 | $3,324 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 13 | $400 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $295 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 6 | $242 |
| ANI Pharmaceuticals, Inc. ANIP | 10 | $207 |
| Ardelyx, Inc. ARDX | 3 | $181 |
| Travere Therapeutics, Inc. TVTX | 6 | $131 |
| Medtronic, Inc. MDT | 1 | $118 |
| Novo Nordisk Inc NVO | 1 | $118 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $98.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.